Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lucid Diagnostics (LUCD) Other Working Capital Changes (2021 - 2025)

Lucid Diagnostics (LUCD) has disclosed Other Working Capital Changes for 5 consecutive years, with $283000.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Other Working Capital Changes rose 164.32% year-over-year to $283000.0, compared with a TTM value of $1.1 million through Sep 2025, up 196.92%, and an annual FY2024 reading of -$1.2 million, down 199.91% over the prior year.
  • Other Working Capital Changes was $283000.0 for Q3 2025 at Lucid Diagnostics, down from $757000.0 in the prior quarter.
  • Across five years, Other Working Capital Changes topped out at $1.1 million in Q4 2021 and bottomed at -$992000.0 in Q4 2022.
  • Average Other Working Capital Changes over 5 years is $113210.5, with a median of $142000.0 recorded in 2023.
  • The sharpest move saw Other Working Capital Changes plummeted 409.86% in 2024, then soared 370.36% in 2025.
  • Year by year, Other Working Capital Changes stood at $1.1 million in 2021, then plummeted by 187.48% to -$992000.0 in 2022, then skyrocketed by 89.72% to -$102000.0 in 2023, then grew by 7.84% to -$94000.0 in 2024, then soared by 401.06% to $283000.0 in 2025.
  • Business Quant data shows Other Working Capital Changes for LUCD at $283000.0 in Q3 2025, $757000.0 in Q2 2025, and $185000.0 in Q1 2025.